This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freydiere, A. M.
Right arrow Articles by Verweij, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freydiere, A. M.
Right arrow Articles by Verweij, P. E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 2004, p. 4870-4872, Vol. 42, No. 10
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.10.4870-4872.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Routine Use of a Commercial Test, GLABRATA RTT, for Rapid Identification of Candida glabrata in Six Laboratories

A. M. Freydiere,1* J. D. Perry,2 O. Faure,3 B. Willinger,4 A. M. Tortorano,5 A. Nicholson,2 J. Peman,6 and P. E. Verweij7

Hopital Debrousse, Hospices Civils de Lyon, Lyon,1 Centre Hospitalier Universitaire, Grenoble, France,3 Freeman Hospital, Newcastle upon Tyne, United Kingdom,2 Division of Clinical Microbiology, Institute of Hygiene and Medical Microbiology, Medical University of Vienna, Vienna, Austria,4 Universita degli Studi di Milano, Milan, Italy,5 Hospital Universitario La Fe, Valencia, Spain,6 Department of Medical Microbiology, University Medical Center, Nijmegen, The Netherlands7

Received 30 March 2004/ Returned for modification 10 May 2004/ Accepted 6 July 2004

When evaluated in six clinical laboratories from six countries with 1,174 fresh isolates, including 715 Candida glabrata and 459 non-C. glabrata strains, GLABRATA RTT (Fumouze Diagnostics, Levallois Perret, France) yielded an overall sensitivity and an overall specificity of 95.8 and 98.9%, respectively. The results were consistent from one laboratory to another. The five false-positive results corresponded to C. parapsilosis (n = 2), C. tropicalis, C. guilliermondii, and C. lusitaniae. GLABRATA RTT allows a rapid, cost-effective, and reliable presumptive identification of C. glabrata.

* Corresponding author. Mailing address: Laboratoire de Bactériologie, Hôpital Debrousse, Hospices Civils de Lyon, 29 Rue Soeur Bouvier, 69322 Lyon cedex 05, France. Phone: (33) 4 7238 5816. Fax: (33) 4 7238 5535. E-mail: anne-marie.freydiere{at}chu-lyon.fr.

Journal of Clinical Microbiology, October 2004, p. 4870-4872, Vol. 42, No. 10
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.10.4870-4872.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»